University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

Phase 3

Completed

Conditions: Age Related Macular Degeneration

Interventions: Drug: ranibizumab
Drug: bevacizumab

First Posted Date: 2008-01-15

Last Posted Date: 2017-08-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1208

Registration Number: NCT00593450

Locations: 🇺🇸
Retina Specialists, Towson, Maryland, United States
🇺🇸
Ohio State University Eye Physicians & Surgeons-Retina Division, Dublin, Ohio, United States
🇺🇸
Texas Retina Associates, Dallas, Texas, United States

and more 48 locations

Multipeptide Vaccine for Advanced Breast Cancer

Phase 1

Completed

Conditions: Breast Neoplasm
Breast Cancer
Cancer of the Breast
Carcinoma, Ductal

Interventions: Biological: hTERT/Survivin Multi-Peptide Vaccine

First Posted Date: 2007-12-14

Last Posted Date: 2016-09-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT00573495

Locations: 🇺🇸
University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States

Chantix for Treating Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: varenicline
Drug: placebo

First Posted Date: 2007-12-04

Last Posted Date: 2013-11-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 37

Registration Number: NCT00567008

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Childhood Adenotonsillectomy Study for Children With OSAS

Not Applicable

Completed

Conditions: Snoring
Obstructive Sleep Apnea

Interventions: Other: Watchful Waiting
Procedure: Adenotonsillectomy (AT) - removal of adenoids and tonsils

First Posted Date: 2007-11-20

Last Posted Date: 2015-12-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 453

Registration Number: NCT00560859

Locations: 🇺🇸
Cardinal Glennon Children's Medical Center, St. Louis, Missouri, United States
🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 3 locations

Effect of HIV/STD Risk Reduction Program on South African Adolescents

Phase 2

Completed

Conditions: HIV Infections
Sexually Transmitted Disease

Interventions: Behavioral: HIV/STD Risk-Reduction
Behavioral: Health Promotion

First Posted Date: 2007-11-16

Last Posted Date: 2015-09-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1057

Registration Number: NCT00559403

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Recruiting

Conditions: Primary Graft Dysfunction
Lung Transplantation

First Posted Date: 2007-11-01

Last Posted Date: 2024-07-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1150

Registration Number: NCT00552357

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser

Phase 2

Completed

Conditions: Cutaneous Lupus Erythematosus

First Posted Date: 2007-08-31

Last Posted Date: 2010-06-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT00523588

Locations: 🇺🇸
University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States

Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study

Phase 4

Terminated

Conditions: PMS

Interventions: Drug: escitalopram
Other: placebo

First Posted Date: 2007-08-31

Last Posted Date: 2014-06-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT00523705

Locations: 🇺🇸
Dept OB/GYN, Mudd Professorship Suite, Philadelphia, Pennsylvania, United States

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Phase 4

Terminated

Conditions: Transplants and Implants

Interventions: Drug: Enteric coated mycophenolate sodium
Drug: Mycophenolate mofetil

First Posted Date: 2007-08-29

Last Posted Date: 2018-01-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 37

Registration Number: NCT00522548

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Ghrelin in Healthy and Frail Older Women

Phase 1

Completed

Conditions: Frailty

Interventions: Drug: Ghrelin Infusion - Healthy
Drug: Ghrelin Infusion - Frail
Other: Placebo Infusion -Healthy
Other: Placebo Infusion - Frail

First Posted Date: 2007-08-27

Last Posted Date: 2019-06-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT00520884

Locations: 🇺🇸
University of Pennsylvania Clinical and Translational Research Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy